Report: Boston Scientific could still seek to pull Synergy stent from India

Boston Scientific (NYSE:BSX) is reportedly still considering a market withdrawal in India for its Synergy adsorbable polymer stent, after repeated attempts to lift a government-imposed price cap were rebuffed by regulators there. Representatives from the Marlborough, Mass.-based medical device giant met yesterday with National Pharmaceutical Pricing Authority officials to discuss pulling Synergy from India, according to LiveMint. The NPPA last week said no changes to the price caps would be considered until February 2018, a year after the caps went into effect, according to the website, which cited a ” person privy to the development.” Get the full story on our sister site, Drug Delivery Business News. The post Report: Boston Scientific could still seek to pull Synergy stent from India appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Stents Wall Street Beat Boston Scientific Indian National Pharmaceutical Pricing Authority (NPPA) Meril Life Science Source Type: news